| Financial Year |
March 31 2023 |
| Monetary Funds |
96,975,885.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
30,860,174.70 |
| Accounts Receivable |
93,895,706.48 |
| Advances to Suppliers |
30,470,336.50 |
| Other Receivables |
210,170,322.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
295,699,666.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,552,246.78 |
| Total Current Assets |
793,888,389.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,350,001,825.13 |
| Under-construction Projects |
105,380,504.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
119,660,064.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
134,129,350.85 |
| Other Non-Current Assets |
19,481,737.84 |
| Sub-Total of Non-Current Assets |
1,747,497,899.09 |
| Total Assets |
2,541,386,288.35 |
| Short-Term Loans |
220,682,549.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,961,090.00 |
| Accounts Payable |
454,024,215.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,229,200.27 |
| Taxes Payable |
30,299,109.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
176,635,860.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
161,694,999.63 |
| Other Current Liabilities |
1,175,676.87 |
| Sub-Total of Current Liabilities |
1,139,373,918.61 |
| Long-term Loans |
9,990,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,591,856.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,613,860.27 |
| Total Liabilities |
1,188,987,778.88 |
| Paid-In Capital(Or Share Stock) |
570,170,000.00 |
| Capital Surplus |
375,338,409.68 |
| Surplus Reserve |
243,370,891.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,435,479.97 |
| Minority Stockholder's Interest |
-138,875,357.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,491,273,866.86 |
| Owner's Equity（Stockholder's Equity） |
1,352,398,509.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,541,386,288.35 |
